Kangji Medical Holdings Limited (HKG:9997)

Market Cap	9.05B
Revenue (ttm)	1.07B
Net Income (ttm)	618.75M
Shares Out	1.21B
EPS (ttm)	0.53
PE Ratio	14.23
Forward PE	13.67
Dividend	0.26 (3.50%)
Ex-Dividend Date	May 27, 2025

Volume	3,176,424
Average Volume	5,337,355
Open	7.49
Previous Close	7.49
Day's Range	7.34 - 7.59
52-Week Range	4.91 - 8.82
Beta	0.31
RSI	43.80
Earnings Date	Aug 20, 2025

About Kangji Medical Holdings

Kangji Medical Holdings Limited, an investment holding company, designs, develops, manufactures, and sells minimally invasive surgical instruments and accessories in Mainland China and internationally. The company offers disposable consumables, disposable trocars, disposable electrocoagulation forceps, ultrasonic scalpels, staplers and other disposable products. It provides reusable ultrasonic scalpels soft tissue cutting and hemostatic scalpel, and laparoscopic surgical instrument. In addition, the company offers instruments, including 4K UHD ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2004
• Employees: 1,007
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 9997

Financial Performance

In 2024, Kangji Medical Holdings's revenue was 1.01 billion, an increase of 8.92% compared to the previous year's 926.02 million. Earnings were 581.44 million, an increase of 15.36%.

Financial numbers in CNY